DiviDrip · KURE

KURE — KraneShares MSCI All China Health Care Index ETF

KURE is KraneShares's KraneShares MSCI All China Health Care Index ETF (Healthcare). Trading at $16.07. Current dividend yield: 4.14%.

Dividend snapshot

Annual dividend rate$0.71
Current yield4.14%
Payment frequencyAnnually
Next ex-dividend dateDec 22, 2026
Most recent payment dateDec 23, 2025
Last payment amount$0.7147
5-year dividend CAGR
3-year dividend CAGR315.05%
Expense ratio0.65%
Payout ratio0%
Market cap$82M
ExchangePCX

Recent dividend payments

DateAmount / share
2025-12-22$0.7150
2024-12-17$0.1840

About KURE

The fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index is a free float adjusted market capitalization weighted index, subject to the 10/40 Constraint, which is designed to measure the equity market performance of Chinese companies in the healthcare sector. The fund is non-diversified.

Track KURE in DiviDrip

Add KURE to your portfolio on DiviDrip to track every buy, DRIP reinvestment, and dividend payment in one place. Free, no credit card, no upsell — built by dividend investors, for dividend investors.

Data refreshed 2026-05-24. Not investment advice. Yields and prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow

Made with Emergent